Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre

被引：0
|
作者：
Shouki Bazarbashi
Mohamed Aseafan
Tasnim Elgazzar
Maha Alkhayat
Abdulrahman Alghabban
Marwa I. Abdelgawad
Bader Alshamsan
Aisha Alshibany
Tusneem Elhassan
Ali Aljubran
Ahmed Alzahrani
Hindi Alhindi
Hussein Raef
机构：
[1] Section of Medical Oncology,College of Medicine
[2] Oncology Center,Section of Medical Oncology, Department of Internal Medicine
[3] King Faisal Specialist Hospital and Research Center,Clinical Oncology Department
[4] Alfaisal University,Department of Medicine, College of Medicine
[5] Security Forces Hospital Program,Department of Pathology and Laboratory Medicine
[6] Assiut University,Section of Endocrinology, Department of Internal Medicine
[7] Qassim University,undefined
[8] Oncology Center,undefined
[9] King Faisal Specialist Hospital and Research Center,undefined
[10] King Faisal Specialist Hospital and Research Center,undefined
[11] King Faisal Specialist Hospital and Research Center,undefined
来源：
BMC Endocrine Disorders | / 23卷
关键词：
Neuroendocrine tumor; Gastroenteropancreatic; GEP-NET; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Gastroenteropancreatic neuroendocrine tumors: diagnosis and treatment
    Diez, Marc
    Teule, Alexandre
    Salazar, Ramon
    ANNALS OF GASTROENTEROLOGY, 2013, 26 (01): : 29 - 36
  • [12] A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients gastroenteropancreatic with functional neuroendocrine tumors
    Berkovic, Maja Cigrovski
    Altabas, Velimir
    Herman, Davorka
    Hrabar, Davor
    Goldoni, Vesna
    Vizner, Branka
    Zjacic-Rotkvic, Vanja
    COLLEGIUM ANTROPOLOGICUM, 2007, 31 (02) : 531 - 534
  • [13] THROMBOTIC RISK IN GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS: A SINGLE CENTRE EXPERIENCE
    Massironi, S.
    Cavalcoli, F.
    Artoni, A.
    Sciola, V.
    Zilli, A.
    Ciafardini, C.
    Rossi, R. E.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E81 - E81
  • [14] Thrombotic Risk in Gastroenteropancreatic Neuroendocrine Tumors: A Single Centre Experience
    Cavalcoli, F. A.
    Rossi, R. E.
    Artoni, A.
    Sciola, V
    Zilli, A.
    Ciafardini, C.
    Massironi, S.
    NEUROENDOCRINOLOGY, 2018, 106 : 65 - 65
  • [15] Surveillance Patterns of Gastroenteropancreatic Neuroendocrine Tumors at Community and Tertiary Centres
    Watanabe, A.
    McKendry, G. J.
    Yip, L.
    Loree, J.
    Stuart, H. C.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S81 - S81
  • [16] Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
    Cives, Mauro
    Pelle', Eleonora
    Strosberg, Jonathan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 13
  • [17] Systemic therapy in the treatment of gastroenteropancreatic neuroendocrine tumors
    Deptala, Andrzej
    Asendrych, Alicja
    Omyla-Staszewska, Joanna
    Rzymkowska, Joanna
    PRZEGLAD GASTROENTEROLOGICZNY, 2006, 1 (01): : 10 - 15
  • [18] Gastroenteropancreatic Neuroendocrine Tumors: Hormonal Treatment Updates
    Khagi, Simon
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2014, 15 (02): : 135 - 137
  • [19] Resistance to targeted treatment of gastroenteropancreatic neuroendocrine tumors
    Beyens, Matthias
    Vandamme, Timon
    Peeters, Marc
    Van Camp, Guy
    Op de Beeck, Ken
    ENDOCRINE-RELATED CANCER, 2019, 26 (03) : R109 - R130
  • [20] Update on the Role of Somatostatin Analogs for the Treatment of Patients With Gastroenteropancreatic Neuroendocrine Tumors
    Toumpanakis, Christos
    Caplin, Martyn E.
    SEMINARS IN ONCOLOGY, 2013, 40 (01) : 56 - 68
12345